改良经尿道前列腺剜除切除术治疗大于80mL前列腺的疗效
本研究比较改良经尿道前列腺剜除切除术(M-TUERP)与常规双极经尿道前列腺电切术(B-TURP)治疗前列腺体积大于80mL患者的效果。86例患者分组研究,M-TUERP组在切除组织重量、术中膀胱平均压力、血红蛋白下降、膀胱冲洗时间及尿道导尿管留置时间方面显著优于B-TURP组,且3年随访时国际前列腺症状评分、最大尿流率和生活质量评分更佳。
要点
- M-TUERP在切除组织重量、术中膀胱平均压力、血红蛋白下降等方面显著优于B-TURP。
- M-TUERP组无输血、血块潴留、重新置管、排尿困难及再手术发生。
- 3年随访时M-TUERP组的IPSS、最大尿流率和生活质量评分更优。
核心结论
- 改良经尿道前列腺剜除切除术是治疗大体积良性前列腺增生的安全有效方法,可简化手术步骤、减少并发症、降低难度并缩短学习曲线,3年随访显示优于B-TURP的持久临床结果。
研究设计与样本
- 2012年4月至2014年5月,86例前列腺体积大于80mL的患者被分为M-TUERP组和B-TURP组进行对照研究。
主要发现
- 两组术前特征无显著差异,手术时间相似。
- M-TUERP组在切除组织重量、术中膀胱平均压力、血红蛋白下降、膀胱冲洗时间及尿道导尿管留置时间方面显著优于B-TURP组。
- 两组均无经尿道电切综合征和尿失禁发生。
- 与B-TURP组相比,M-TUERP组无患者发生输血、血块潴留、重新置管、排尿困难及再手术。
- 3年随访时,M-TUERP组的国际前列腺症状评分、最大尿流率和生活质量评分均优于B-TURP组。
临床怎么用
- 对于前列腺体积大于80mL的良性前列腺增生患者,可考虑采用改良经尿道前列腺剜除切除术,以简化手术、减少并发症并缩短学习曲线。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the efficacy and safety of the modified transurethral enucleation and resection of the prostate (M-TUERP) vs the conventional bipolar transurethral resection of the prostate (B-TURP) for the treatment of prostates larger than 80 mL. METHODS: From April 2012 to May 2014, 86 patients with a prostate volume of >80 mL were divided into 2 groups to undergo M-TUERP and B-TURP. In the M-TUERP group, we proposed combining the 12-mm trocar suprapubic cystostomy and using the techniques of "umbrella-shaped resection," "point resection," and "segmental enucleation" to modify the transurethral enucleation and resection of the prostate procedure. The perioperative clinical data were recorded and analyzed. RESULTS: There were no significant differences in preoperative characteristics between the 2 groups. Both groups were similar with the operative time. The M-TUERP group was significantly superior to the B-TURP group in terms of the weight of the resected tissue, the mean intraoperative bladder pressure, hemoglobin decrease, bladder irrigation duration, and urethral catheterization time. No transurethral resection syndrome and incontinence occurred in either group. Compared with the B-TURP group, none of the patients in the M-TUERP group suffered blood transfusion, clot retention, recatheterization, dysuria and reoperation. At the 3-year follow-up, patients who underwent M-TUERP had better international prostate symptom scores, maximum urinary flow rates, and quality of life scores. CONCLUSION: Our modification of the transurethral enucleation and resection of the prostate procedure is a safe and effective method for the surgical treatment of large-volume benign prostatic hyperplasia. It can simplify the surgical procedures, reduce complications, lower difficulties and shorten the learning curve. At 3-year follow-up, the M-TUERP shows a superior and durable clinical outcome than the B-TURP.
引用
- Li K, Wang D, Hu C, et al. A Novel Modification of Transurethral Enucleation and Resection of the Prostate in Patients With Prostate Glands Larger than 80 mL: Surgical Procedures and Clinical Outcomes. Urology. 2018. PMID: 29203184. doi:10.1016/j.urology.2017.11.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。